Back to User profile » Dr Lingyan Xu
Paper published by Dr Lingyan Xu:
Original Research
Oncology
The Pan-Cancer Analysis Uncovers the Prognostic and Immunotherapeutic Significance of CD19 as an Immune Marker in Tumor
Wei L, Meng J, Xiang D, Yang Q, Zhou Y, Xu L, Chen J, Han Y
International Journal of General Medicine 2024, 17:2593-2612
Published Date: 4 June 2024